NCT00579800View on ClinicalTrials.gov

Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Breast Cancer
Interventions
PROCEDURE

new software sequences, FIESTA and Vibrant-DE and IDEAL

Conventional images will be taken using the standard sequences consisting of T2-weighted imaging and T1-weighted imaging before and after contrast; these will be used for the diagnostic examination. FIESTA will be performed on 50 patients, while Vibrant-DE and IDEAL will be performed on the other 50 patients.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00579800 - Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation | Biotech Hunter | Biotech Hunter